Literature DB >> 22544427

Posterior reversible encephalopathy syndrome due to immunosuppressant after living-donor lobar lung transplantation: report of a case.

Tsuyoshi Shoji1, Toru Bando, Takuji Fujinaga, Fengshi Chen, Mitsutomo Kohno, Miharu Yabe, Hiromasa Yabe, Hiroshi Date.   

Abstract

Living-donor lobar lung transplantation was performed in a 10-year-old boy with bronchiolitis obliterans after bone marrow transplantation for recurrent acute myeloid leukemia. He developed posterior reversible encephalopathy syndrome (PRES) due to calcineurin inhibitor (CNI) postoperatively, which was recovered with suspension of CNI. PRES should be considered one of the important morbidity after lung transplantation.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22544427     DOI： 10.1007/s11748-012-0030-6

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN： 1863-6705


  8 in total

1.  Living-donor lobar lung transplantation experience: intermediate results.

Authors:  V A Starnes; M L Barr; R G Cohen; J A Hagen; W J Wells; M V Horn; F A Schenkel
Journal:  J Thorac Cardiovasc Surg       Date:  1996-11       Impact factor: 5.209

2.  Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases.

Authors:  R B Schwartz; S M Bravo; R A Klufas; L Hsu; P D Barnes; C D Robson; J H Antin
Journal:  AJR Am J Roentgenol       Date:  1995-09       Impact factor: 3.959

3.  Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression.

Authors:  C Horbinski; W S Bartynski; E Carson-Walter; R L Hamilton; H P Tan; S Cheng
Journal:  AJNR Am J Neuroradiol       Date:  2008-10-14       Impact factor: 3.825

4.  Posterior reversible encephalopathy syndrome after solid organ transplantation.

Authors:  W S Bartynski; H P Tan; J F Boardman; R Shapiro; J W Marsh
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-13       Impact factor: 3.825

5.  Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients?

Authors:  Narayan Prasad; Sanjeev Gulati; Rakesh Kumar Gupta; Rajesh Kumar; Kumudini Sharma; Raj Kumar Sharma
Journal:  Pediatr Nephrol       Date:  2003-09-19       Impact factor: 3.714

6.  CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors.

Authors:  B Erer; P Polchi; G Lucarelli; E Angelucci; D Baronciani; M Galimberti; C Giardini; D Gaziev; A Maiello
Journal:  Bone Marrow Transplant       Date:  1996-07       Impact factor: 5.483

Review 7.  Neuroimaging in posterior reversible encephalopathy syndrome.

Authors:  C Lamy; C Oppenheim; J F Méder; J L Mas
Journal:  J Neuroimaging       Date:  2004-04       Impact factor: 2.486

8.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245
  8 in total
  2 in total

Review 1.  Posterior Reversible Encephalopathy Syndrome After Transplantation: a Review.

Authors:  Sheng Chen; Jun Hu; Liang Xu; Dixon Brandon; Jun Yu; Jianmin Zhang
Journal:  Mol Neurobiol       Date:  2015-12-14       Impact factor: 5.590

Review 2.  Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation: Report of 2 Cases and Literature Review.

Authors:  Turun Song; Zhengsheng Rao; Qiling Tan; Yang Qiu; Jinpeng Liu; Zhongli Huang; Xianding Wang; Tao Lin
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.